Clinical Trial Update: A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123) [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study evaluated whether Boceprevir affects plasma concentrations of methadone or buprenorphine/naloxone in patients with hepatitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)
• Buprenorphine/naloxone (buprenorphine/naloxone)
• Methadone (methadone)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C Virus | Phase 1 | Status: COMPLETED | Results posted: 2013-03-11